Novel invariant features of Good syndrome

Leukemia. 2021 Jun;35(6):1792-1796. doi: 10.1038/s41375-020-01114-z. Epub 2021 Jan 7.

Carmelo Gurnari^#^{1

2}, Jibran Durrani^#¹, Simona Pagliuca¹, Ashwin Kishtagari¹, Hassan Awada¹, Cassandra M Kerr¹, Vera Adema¹, Sunisa Kongkiatkamon¹, Alan E Lichtin^{1

3}, Bhumika J Patel^{1

3}, Valeria Visconte¹, Mikkael A Sekeres^{1

3}, James R Cook⁴, Jaroslaw P Maciejewski^{5

6}

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.
² Department of Biomedicine and Prevention, Phd in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
³ Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA.
⁴ Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
⁵ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA. [email protected].
⁶ Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA. [email protected].

^# Contributed equally.

No abstract available

Publication types